![Anissa L. Leh](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Anissa L. Leh
Keine laufenden Positionen mehr
Profil
Anissa L.
Leh worked as a Director of Clinical Operations at Protalex, Inc. before pursuing her undergraduate and graduate degrees at the University of Wisconsin.
Ehemalige bekannte Positionen von Anissa L. Leh
Unternehmen | Position | Ende |
---|---|---|
PROTALEX, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Anissa L. Leh
University of Wisconsin | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Protalex, Inc.
![]() Protalex, Inc. Pharmaceuticals: MajorHealth Technology Protalex, Inc. engages in the development of a class of biopharmaceutical drugs for treating autoimmune and inflammatory diseases including rheumatoid arthritis and Immune Thrombocytopenia. Its lead product is PRTX-100 which is a bacterial protein known to modify aspects of the human immune system. The company was founded by John E. Doherty on September 17, 1999 and is headquartered in Florham Park, NJ. | Health Technology |